-
Recall of Asbestos-contaminated Baby Powder Raises Fear of Mesothelioma
A New Jersey-based medical supply company has issued a recall on 62 cases of asbestos-contaminated baby powder sent to distributors in 12 states, raising concerns over exposure that can lead to malignant mesothelioma and other asbestos-related diseases. The contamination was discovered during a sample testing conducted by the U.S. Food and Drug Administration (FDA).
-
Expert Discusses Challenges in Assessing Surgery’s Role in Treating Mesothelioma
In a recent post on the online medical resource OncLive, the director of the New York Mesothelioma Program at the Icahn School of Medicine at Mount Sinai discussed the challenges of randomized controlled trials in assessing the role of surgery in treating the rare form of cancer. Andrea Wolf, MD, MPH, pointed to issues in
-
European Union Data Reveals Impact of Mesothelioma
An official website of the European Union (EU) marked Mesothelioma Awareness Day (September 26th) with an article reviewing the most recent statistics on the impact of the rare asbestos-related disease on the EU population.
-
Oxygen-Dependent Philadelphia Asbestosis Victim Wins $25 Million Jury Verdict
Asbestos exposure puts people at risk for several significant illnesses, with malignant mesothelioma, asbestos-related lung cancer, and asbestosis representing the most commonly diagnosed. While mesothelioma, a rare and fatal form of cancer, is considered the most serious of these diseases, all three are life-changing. The degree to which even the least life-threatening of these illnesses
-
Chinese Researchers Identify Highly Accurate Mesothelioma Biomarker
Malignant mesothelioma is an aggressive, fatal form of cancer caused by exposure to asbestos. The disease has presented several significant challenges to the medical community, including its resemblance to other, more benign conditions and difficulties in accurately and quickly diagnosing it. Now, researchers from China have published a study identifying a valuable diagnostic and prognostic
-
Jury Awards $39 Million After Talc Used in Medical Procedure Leads to Mesothelioma
In a first-of-its-kind mesothelioma claim, a couple accused a talc supplier’s asbestos-contaminated talc of causing his fatal illness. After a three-week trial, a Massachusetts jury has ordered Cimbar Performance Minerals to pay Bryce and Diane Zundel over $39 million in damages.
-
Johnson & Johnson Files 3rd Bankruptcy Application for Mesothelioma/Ovarian Cancer Claims
Facing 62,000 personal injury claims blaming their talc products for ovarian cancer and malignant mesothelioma diagnoses, Johnson & Johnson has filed an unprecedented third Chapter 11 bankruptcy case that it hopes will end the litigation against it. This version boosts the compensation plan to about $8 billion and has received a vote of confidence from
-
Gene Therapy Company Increases Focus on Mesothelioma Program
Clinical-stage gene therapy company Genprex, Inc. has announced an increased focus on developing a program specifically targeting malignant mesothelioma. The Austin-based company has announced the formation of a mesothelioma clinical advisory board comprised of four world-renowned researchers from major research institutions specializing in the treatment of the rare, asbestos-related disease.
-
First Multi-District Litigation Ovarian Cancer Trial Against J & J Scheduled for December 3, 2024
After years of delays, tens of thousands of ovarian cancer victims and their families will have a first chance at justice on December 3rd, when the first federal bellwether trial accusing Johnson & Johnson’s talcum powder of negligence will be heard in the District of New Jersey. Mesothelioma victims who accuse the company of causing
-
FDA Approves Pembrolizumab Plus Chemotherapy for Unresectable Pleural Mesothelioma
The U.S. Food and Drug Administration has officially approved the use of Pembrolizumab (Keytruda) plus Pemetrexed and platinum chemotherapy as the frontline treatment for patients diagnosed with unresectable advanced or metastatic malignant pleural mesothelioma. The decision was based on data from a study that showed the combination provided significant improvement in overall survival versus chemotherapy
-
Connecticut Mesothelioma Case Highlights Dangers of Talc
A 64-year-old Connecticut man diagnosed with malignant mesothelioma is blaming his illness on Johnson & Johnson’s talcum powder products and filed a personal injury lawsuit in the state’s Bridgeport Judicial District Court. The ongoing trial is attracting significant attention and highlighting concerns over previously unknown dangers of talcum powder in popular consumer products.
-
Mesothelioma Victim Points to Asbestos on Stepfather’s Clothing
David Gomez blames his malignant mesothelioma diagnosis on secondary exposure to asbestos carried into his childhood home on his stepfather’s work clothes. His personal injury lawsuit names several companies that he holds responsible for his illness.
-
Real Estate Mogul’s Mesothelioma Case Moves Forward Following Settlement
The president and chief executive officer of NAI Plotkin, a real estate development company, has settled his mesothelioma claim against the maker of Clubman Talc. His attorney indicated this move should shorten the days needed for his upcoming jury trial. Johnson & Johnson and several of its related companies are among the remaining defendants.
-
Court Orders Shipyard to Produce Family’s Personnel Information for Mesothelioma Victim
After she was diagnosed with malignant mesothelioma, Brenda Palermo filed a personal injury lawsuit against the companies she says exposed her to the asbestos that caused her illness. After she died in March of 2024, her family continued her quest for justice, but Avondale Shipyards refused to provide them with critical information they needed. A
-
Food Worker’s Mesothelioma Blamed on Asbestos in Gloves
The vast majority of people diagnosed with malignant mesothelioma blame years of occupational exposure to asbestos-contaminated products for their illness. The late Warren Stouch pointed to the safety gloves he wore while working in the food industry, and before his death in July 2021, he filed suit against their manufacturer. Though Magid Glove and Safety
-
Asbestos Company Objects to Expert Witness Testimony in Veteran’s Lung Cancer Case
Navy veteran Arnold Edmonds is pursuing justice from more than 20 asbestos companies following his diagnosis of non-small cell lung carcinoma. In support of his claim, he has enlisted expert witness Dr. David Zhang, a physician specializing in pathology and occupational medicine. Two of the companies moved to block his testimony entirely, but the judge
-
Additional $1 Billion May Seal J&J Talc Settlement with Ovarian Cancer Victims
After years of negotiations, an additional $1.1 billion in compensation may be what seals a settlement deal for ovarian cancer victims seeking justice from Johnson & Johnson. If accepted, the agreement would resolve the litigation issues specific to those suffering gynecologic effects from using the company’s baby powder and other talc powder products but does
-
Man’s Mesothelioma Blamed on Asbestos in Talc Used for Pleurodesis
Talc pleurodesis is a medical procedure that is used to prevent the build-up of fluid or air in the pleural lining. It provides relief to patients suffering from several lung conditions, including malignant pleural mesothelioma, but in the case of Salt Lake City, Utah resident Bryce Zundel, the talc used in the procedures he underwent
-
Mesothelioma Victim Wins New Trial Against Stucco Company
The California Court of Appeals has granted mesothelioma victim Kevin Brooks and his wife a new trial after a jury found that Mission Stucco’s products were a substantial factor in Mr. Brooks’ illness but also found that the company had no comparative fault. The appeals court granted a new trial to redetermine the apportionment of fault:
-
Washington State Asbestos Company Fined Over Mismanagement, Risk of Mesothelioma
Before it became known that asbestos causes mesothelioma and other deadly illnesses, it was used in thousands of applications and products, particularly in construction materials. Though that use has stopped, legacy asbestos continues to pose a threat in homes, schools, and other buildings. Asbestos abatement companies remove the toxic material in compliance with local, state, and
